InsidersTradesSigma
Follow the Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso share price and the full management transaction log of the company, a listed equity based in Italy. Shares trade on the IT market, under the supervision of Consob. Operating in the Health Care sector, Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso has recorded 1 public disclosures. Market capitalisation: €799.5m. The latest transaction was reported on 26 May 2023 (Other). All data is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,598 of 29,063 companies
61.7
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 May 2023
关于 Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso
Pharmanutra 是一家专注于健康和制药领域的公司，以其创新产品而闻名。该公司在XMIL市场上市，并与由一级方程式赛车手费尔南多·阿隆索（Fernando Alonso）支持的Cetilar品牌相关联。